- Price
- $361.57
- Day
- +2.08%
- Mkt Cap
- $87.77B
- 52W Range
- $289.86 – $379.65
- Volume
- 1.80M
- Beta
- 1.10
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Sherwin-Williams maintains positive volume and share gains despite weak housing demand, supporting my hold rating. SHW's Q2 results showed 7.5% net sales growth and 9.5% adj. EPS growth, but margin risks persist due to raw material cost pressures. September's 8% price increase may not be fully realized in H2, creating timing risks for margin expansion and consensus earnings estimates.
Read full article
First National Bank of Mount Dora Trust Investment Services lowered its stake in shares of The Sherwin-Williams Company (NYSE: SHW) by 85.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,513 shares of the specialty chemicals company's stock after
Read full article
Wall Street analysts are reshuffling their bets heading into August, and some of the calls on Monday target names that range from a crypto giant to a coffee behemoth to a semiconductor darling. Find out which stocks just got slapped with new downgrades and which ones earned fresh upgrades.
Read full article
Sherwin-Williams delivered a strong Q2 2026, with double-beat results and 7.6% year-over-year revenue growth to $6.79B. SHW raised full-year 2026 EPS guidance to $11.80–$12.20, reflecting robust pricing power and segment gains, despite integration and margin headwinds from Suvinil. My free cash flow valuation model indicates SHW trades at a 12% discount to fair value, supporting a continued Buy rating.
Read full article
Sherwin-Williams NYSE: SHW reported high-single-digit consolidated sales growth in the second quarter of 2026, supported by new account wins, share gains and contributions from the Suvinil acquisition, while management said broad demand conditions remained largely unchanged.
Read full article
Sherwin-Williams tops Q2 earnings and sales estimates as all three segments grow, prompting higher full-year sales and adjusted EPS guidance.
Read full article
Pre-market futures are mixed at this hour, continuing Monday's trading narrative of rotating out of the tech-heavy Nasdaq and into the blue-chip Dow. The Dow, with strong Q2 results from Coke and elsewhere, is up +413 points at present; the Nasdaq — with microchips once again bring sold — is -270 points.
Read full article
Interest rates have not moved since December's quarter-point cut to a range of +3.50-3.75%.
Read full article
While the top- and bottom-line numbers for Sherwin-Williams (SHW) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read full article
Sherwin-Williams (SHW) came out with quarterly earnings of $3.7 per share, beating the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $3.38 per share a year ago.
Read full article
For the year, Sherwin-Williams now expects net sales to be up in the mid- to high-single-digit percent range, compared with a prior outlook for sales growth in the low- to mid-single-digit percent range.
Read full article
The Dow is extending yesterday's gains while the Nasdaq looks to carry in its losses amid volatility
Read full article